Yang zheng Xiao Ji Jiao Nang (0.39g* 36capsules) Adjuvant therapy for liver cancer 养正消积胶囊 YiLing
Free Shipping ! The shipping time is about 1-1.5 months.
- Import duties, taxes and charges are not included in the item price or shipping charges. These charges are the buyer responsibility.
- Please check with your country customs office to determine what these additional costs will be prior to bidding/buying
Description: Capsules, containing brown powder; odor, aromatic; taste, bitter and astringent.
Functions and Indications: Fortify the spleen and tonify kidney, resolve stasis and detoxicate. Used as adjuvant therapy for primary liver cancer due to dual deficiency of the spleen and kidney, internal obstruction of stasis toxin, which were not suitable for operation. Combined with transcatheter hepatic arterial chemoembolization, conduce to raise efficacy of interventional chemotherapy, reduce the toxic effect to the white blood cells, liver function and hemoglobin; improve patients’ quality of life, ameliorate epigastrium distending pain, torpid intake and poor appetite, lassitude of spirit and lack of strength, soreness and weakness of waist and knees, sloppy stool , pains.
Administration and Dosage: For oral administration, 4 capsules once, 3 times daily.
Precautions: Please protect from moisture after opening the moisture proof bag.
Pharmacology and toxicology: Primary pharmacodynamics test showed that: it has inhibitory action to transplanted tumor S180, hepatic carcinoma HAC solid tumor and Lewis lung cancer in mice; It has inhibitory action to human liver cancer SMMC7721 transplanted in nude mice; Combined with low-dose chemotherapeutic drugs, it shows increased efficiency on inhibition of the growth of sarcoma S180 in mice; Promote proliferation of spleen lymphocyte in tumor-bearing mice, NK cell activity and formation of IL-2. It can increase the level of leukopenia induced by cyclophosphamide in mice.
Storage: Preserve in tightly closed containers.
Shelf-life: 30 months
Executive standard: Chinese Pharmacopoeia 2010, volumeⅠ.